Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries

The private for-profit sector is an important source of treatment for malaria. However, private patients face high prices for the recommended treatment for uncomplicated malaria, artemisinin combination therapies (ACTs), which makes them more likely to receive cheaper, less effective non-artemisinin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Health Policy Plan
Prif Awduron: Palafox, Benjamin, Patouillard, Edith, Tougher, Sarah, Goodman, Catherine, Hanson, Kara, Kleinschmidt, Immo, Torres Rueda, Sergio, Kiefer, Sabine, O’Connell, Kate, Zinsou, Cyprien, Phok, Sochea, Akulayi, Louis, Arogundade, Ekundayo, Buyungo, Peter, Mpasela, Felton, Poyer, Stephen, Chavasse, Desmond
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2016
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748126/
https://ncbi.nlm.nih.gov/pubmed/25944705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/heapol/czv031
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg